Abstract
As life expectancy rises, the prevalence of heart failure is steadily increasing, while donors for organ transplantation remain in short supply (Zwi-Dantsis and Gepstein, 2012). Indeed, myocardial infarction represents the foremost cause of death within industrialized nations (Henning, 2011) and further, approximately 1% of all newborns harbor a congenital heart defect. Although medical interventions allow > 80% of those with cardiac defects to survive to adulthood, there are often extreme emotional and financial burdens that accompany such congenital anomalies, and many individuals will remain at a heightened risk for myocardial infarction throughout the remainder of their lives (Verheugt et al., 2010; Amianto et al., 2011). In this review, we will discuss the nature of the failing heart and strategies for repair from an epigenetic standpoint. Significant focus will reside on pluripotent-to-cardiomyocyte differentiation for cell replacement, epigenetic mechanisms of cardiomyocyte differentiation, epigenetic “memories,” and epigenetic control of cardiomyocyte cell fate toward translational utility.
Similar content being viewed by others
References
Ahmed W, Ali I S, Riaz M, Younas A, Sadeque A, Niazi A K, Niazi S H, Ali S H B, Azam M, Qamar R (2013). Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia. Gene, 515(2): 416–420
Amianto F, Bergui G, Abbate-Daga G, Bellicanta A, Munno D, Fassino S (2011). Growing up with a congenital heart disease: neurocognitive, psychopathological and quality of life outcomes. Panminerva Med, 53(2): 109–127
Anderson D, Self T, Mellor I R, Goh G, Hill S J, Denning C (2007). Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther, 15(11): 2027–2036
Antos C L, McKinsey T A, Dreitz M, Hollingsworth L M, Zhang C L, Schreiber K, Rindt H, Gorczynski R J, Olson E N (2003). Dosedependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem, 278(31): 28930–28937
Arya G, Maitra A, Grigoryev S A (2010). A structural perspective on the where, how, why, and what of nucleosome positioning. J Biomol Struct Dyn, 27(6): 803–820
Awad S, Kunhi M, Little G H, Bai Y, An W, Bers D, Kedes L, Poizat C (2013). Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy. Nucleic Acids Res, 41(16): 7656–7672
Backs J, Song K, Bezprozvannaya S, Chang S, Olson E N (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest, 116(7): 1853–1864
Bannister A J, Kouzarides T (2011). Regulation of chromatin by histone modifications. Cell Res, 21(3): 381–395
Bar-Nur O, Russ H A, Efrat S, Benvenisty N (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell, 9(1): 17–23
Bergmann O, Bhardwaj R D, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz B A, Druid H, Jovinge S, Frisén J (2009). Evidence for cardiomyocyte renewal in humans. Science, 324(5923): 98–102
Bossuyt J, Helmstadter K, Wu X, Clements-Jewery H, Haworth R S, Avkiran M, Martin J L, Pogwizd S M, Bers D M (2008). Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ Res, 102(6): 695–702
Brito-Martins M, Harding S E, Ali N N (2008). beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol, 153(4): 751–759
Brons I G, Smithers L E, Trotter M W, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes S M, Howlett S K, Clarkson A, Ahrlund-Richter L, Pedersen R A, Vallier L (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448(7150): 191–195
Cai X, Hagedorn C H, Cullen B R (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10(12): 1957–1966
Cai Y, Geutjes E J, de Lint K, Roepman P, Bruurs L, Yu L R, Wang W, van Blijswijk J, Mohammad H, de Rink I, Bernards R, Baylin S B (2014). The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes. Oncogene, 33(17): 2157–2168
Carpenter L, Carr C, Yang C T, Stuckey D J, Clarke K, Watt SM (2012). Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev, 21(6): 977–986
Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L (2007a). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol, 50(19): 1884–1893
Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib I H, Gepstein L, Levenberg S (2007b). Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res, 100(2): 263–272
Chang S, McKinsey T A, Zhang C L, Richardson J A, Hill J A, Olson E N (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol, 24(19): 8467–8476
Chen J, Huang Z P, Seok H Y, Ding J, Kataoka M, Zhang Z, Hu X, Wang G, Lin Z, Wang S, Pu W T, Liao R, Wang D Z (2013). mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res, 112(12): 1557–1566
Chen T, Dent S Y (2014). Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet, 15(2): 93–106
Chimenti I, Gaetani R, Barile L, Forte E, Ionta V, Angelini F, Frati G, Messina E, Giacomello A (2012). Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol, 879: 327–338
Choi S C, Yoon J, Shim W J, Ro Y M, Lim D S (2004). 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med, 36(6): 515–523
Chong J J, Yang X, Don CW, Minami E, Liu YW, Weyers J J, Mahoney W M, Van Biber B, Cook S M, Palpant N J, Gantz J A, Fugate J A, Muskheli V, Gough G M, Vogel K W, Astley C A, Hotchkiss C E, Baldessari A, Pabon L, Reinecke H, Gill E A, Nelson V, Kiem H P, Laflamme M A, Murry C E (2014). Human embryonic-stem-cellderived cardiomyocytes regenerate non-human primate hearts. Nature, 510(7504): 273–277
Chow M, Boheler K R, Li R A (2013a). Human pluripotent stem cellderived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res Ther, 4(4): 97
Chow M Z, Geng L, Kong CW, Keung W, Fung J C, Boheler K R, Li R A (2013b). Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Stem Cells Dev, 22(19): 2678–2690
Cohen S M (2014). Everything old is new again: (linc)RNAs make proteins! EMBO J, 33(9): 937–938
Cohn J N, Ferrari R, Sharpe N (2000). Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol, 35(3): 569–582
Coppola A, Romito A, Borel C, Gehrig C, Gagnebin M, Falconnet E, Izzo A, Altucci L, Banfi S, Antonarakis S E, Minchiotti G, Cobellis G (2014). Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. Stem Cell Res, 12(2): 323–337
Dimmeler S, Zeiher A M, Schneider M D (2005). Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest, 115(3): 572–583
Djebali S, Davis C A, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov G K, Khatun J, Williams B A, Zaleski C, Rozowsky J, Röder M, Kokocinski F, Abdelhamid R F, Alioto T, Antoshechkin I, Baer MT, Bar N S, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood M J, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo O J, Park E, Persaud K, Preall J B, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See L H, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis S E, Hannon G, Giddings M C, Ruan Y, Wold B, Carninci P, Guigó R, Gingeras T R (2012). Landscape of transcription in human cells. Nature, 489(7414): 101–108
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall T J, Delphin E S, Zhang C (2009). MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem, 284(43): 29514–29525
Dubois N C, Craft A M, Sharma P, Elliott D A, Stanley E G, Elefanty A G, Gramolini A, Keller G (2011). SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol, 29(11): 1011–1018
ENCODE Project Consortium (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414): 57–74
Fan D, Takawale A, Lee J, Kassiri Z (2012). Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair, 5(1): 15
Felician G, Collesi C, Lusic M, Martinelli V, Ferro M D, Zentilin L, Zacchigna S, Giacca M (2014). Epigenetic modification at Notch responsive promoters blunts efficacy of inducing notch pathway reactivation after myocardial infarction. Circ Res, 115(7): 636–649
Feng Y, Wang J, Asher S, Hoang L, Guardiani C, Ivanov I, Zheng Y G (2011). Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism. J Biol Chem, 286(23): 20323–20334
Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, Femminella G D, Leosco D, Bonaduce D (2014). β-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol, 4: 396
Fisher C L, Fisher A G (2011). Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr Opin Genet Dev, 21(2): 140–146
Fu J D, Rushing S N, Lieu D K, Chan C W, Kong CW, Geng L, Wilson K D, Chiamvimonvat N, Boheler K R, Wu J C, Keller G, Hajjar R J, Li R A (2011). Distinct roles of microRNA-1 and-499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One, 6(11): e27417
Fukushige S, Kondo E, Horii A (2008). Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells. Biochem Biophys Res Commun, 377(2): 600–605
Gadue P, Huber T L, Paddison P J, Keller G M (2006). Wnt and TGFbeta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci U S A, 103(45): 16806–16811
Gafni O, Weinberger L, Mansour A A, Manor Y S, Chomsky E, Ben-Yosef D, Kalma Y, Viukov S, Maza I, Zviran A, Rais Y, Shipony Z, Mukamel Z, Krupalnik V, Zerbib M, Geula S, Caspi I, Schneir D, Shwartz T, Gilad S, Amann-Zalcenstein D, Benjamin S, Amit I, Tanay A, Massarwa R, Novershtern N, Hanna J H (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504(7479): 282–286
Gepstein L, Ding C, Rahmutula D, Wilson E E, Yankelson L, Caspi O, Gepstein A, Huber I, Olgin J E (2010). In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells, 28(12): 2151–2161
Gopalakrishnan S, Van Emburgh B O, Robertson K D (2008). DNA methylation in development and human disease. Mutat Res, 647(1–2): 30–38
Graichen R, Xu X, Braam S R, Balakrishnan T, Norfiza S, Sieh S, Soo S Y, Tham S C, Mummery C, Colman A, Zweigerdt R, Davidson B P (2008). Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation, 76(4): 357–370
Grote P, Herrmann B G (2013). The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol, 10(10): 1579–1585
Grote P, Wittler L, Hendrix D, Koch F, Währisch S, Beisaw A, Macura K, Bläss G, Kellis M, Werber M, Herrmann B G (2013). The tissuespecific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell, 24(2): 206–214
Gu Y, Liu G H, Plongthongkum N, Benner C, Yi F, Qu J, Suzuki K, Yang J, Zhang W, Li M, Montserrat N, Crespo I, Del Sol A, Esteban C R, Zhang K, Izpisua Belmonte J C (2014). Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes. Protein Cell, 5(1): 59–68
Guo J U, Su Y, Shin J H, Shin J, Li H, Xie B, Zhong C, Hu S, Le T, Fan G, Zhu H, Chang Q, Gao Y, Ming G L, Song H (2014). Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci, 17(2): 215–222
Gupta M K, Rao T N (2014). Hearty miR-363 controls HAND1 in cardiac cell specification. Stem Cell Res Ther, 5(4): 89
Haas J, Frese K S, Park Y J, Keller A, Vogel B, Lindroth A M, Weichenhan D, Franke J, Fischer S, Bauer A, Marquart S, Sedaghat-Hamedani F, Kayvanpour E, Köhler D, Wolf N M, Hassel S, Nietsch R, Wieland T, Ehlermann P, Schultz J H, Dösch A, Mereles D, Hardt S, Backs J, Hoheisel J D, Plass C, Katus H A, Meder B (2013). Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med, 5(3): 413–429
Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R, Gruh I, Meyer J, Wagner S, Maier L S, Han DW, Glage S, Miller K, Fischer P, Schöler H R, Martin U (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 5(4): 434–441
Halbach M, Pfannkuche K, Pillekamp F, Ziomka A, Hannes T, Reppel M, Hescheler J, Müller-Ehmsen J (2007). Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res, 101(5): 484–492
Han P, Li W, Lin C H, Yang J, Shang C, Nurnberg S T, Jin K K, Xu W, Lin C Y, Lin C J, Xiong Y, Chien H C, Zhou B, Ashley E, Bernstein D, Chen P S, Chen H S, Quertermous T, Chang C P (2014). A long noncoding RNA protects the heart from pathological hypertrophy. Nature, 514(7520): 102–106
Handy D E, Castro R, Loscalzo J (2011). Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation, 123(19): 2145–2156
Hang C T, Yang J, Han P, Cheng H L, Shang C, Ashley E, Zhou B, Chang C P (2010). Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature, 466(7302): 62–67
Hanna J, Cheng AW, Saha K, Kim J, Lengner C J, Soldner F, Cassady J P, Muffat J, Carey B W, Jaenisch R (2010). Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A, 107(20): 9222–9227
Hansen T B, Jensen T I, Clausen B H, Bramsen J B, Finsen B, Damgaard C K, Kjems J (2013). Natural RNA circles function as efficient microRNA sponges. Nature, 495(7441): 384–388
Hattori F, Chen H, Yamashita H, Tohyama S, Satoh Y S, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oikawa S, Fukuda K (2010). Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods, 7(1): 61–66
Henning R J (2011). Stem cells in cardiac repair. Future Cardiol, 7(1): 99–117
Hirt MN, Boeddinghaus J, Mitchell A, Schaaf S, Börnchen C, Müller C, Schulz H, Hubner N, Stenzig J, Stoehr A, Neuber C, Eder A, Luther P K, Hansen A, Eschenhagen T (2014). Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol, 74: 151–161
Ho L, Crabtree G R (2010). Chromatin remodelling during development. Nature, 463(7280): 474–484
Hoekstra M, van der Lans C A, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel T J C, Biessen E A L (2010). The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun, 394(3): 792–797
Horrillo A, Pezzolla D, Fraga M F, Aguilera Y, Salguero-Aranda C, Tejedo J R, Martin F, Bedoya F J, Soria B, Hmadcha A (2013). Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment. Cell Death Dis, 4(4): e570
Horton R E, Millman J R, Colton C K, Auguste D T (2009). Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes. Regen Med, 4(5): 721–732
Hough S R, Laslett A L, Grimmond S B, Kolle G, Pera M F (2009). A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS One, 4(11): e7708
Huang V, Li L C (2012). miRNA goes nuclear. RNA Biol, 9(3): 269–273
Huang Z P, Chen J, Seok H Y, Zhang Z, Kataoka M, Hu X, Wang D Z (2013). MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res, 112(9): 1234–1243
Ikeda S, Kong S W, Lu J, Bisping E, Zhang H, Allen P D, Golub T R, Pieske B, Pu W T (2007). Altered microRNA expression in human heart disease. Physiol Genomics, 31(3): 367–373
Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Saito S, Nakamura Y, Tanaka T (2006). Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet, 51(12): 1087–1099
Jaguszewski M, Osipova J, Ghadri J R, Napp L C, Widera C, Franke J, Fijalkowski M, Nowak R, Fijalkowska M, Volkmann I, Katus H A, Wollert K C, Bauersachs J, Erne P, Lüscher T F, Thum T, Templin C (2014). A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur Heart J, 35(15): 999–1006
Jenuwein T, Allis C D (2001). Translating the histone code. Science, 293(5532): 1074–1080
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna J A, Charpentier E (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096): 816–821
Karamboulas C, Swedani A, Ward C, Al-Madhoun A S, Wilton S, Boisvenue S, Ridgeway A G, Skerjanc I S (2006). HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J Cell Sci, 119(Pt 20): 4305–4314
Kattman S J, Witty A D, Gagliardi M, Dubois N C, Niapour M, Hotta A, Ellis J, Keller G (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8(2): 228–240
Kavi H H, Birchler J A (2009). Interaction of RNA polymerase II and the small RNA machinery affects heterochromatic silencing in Drosophila. Epigenetics Chromatin, 2(1): 15
Kawamura T, Ono K, Morimoto T, Wada H, Hirai M, Hidaka K, Morisaki T, Heike T, Nakahata T, Kita T, Hasegawa K (2005). Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem, 280(20): 19682–19688
Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 108(3): 407–414
Kehat I, Molkentin J D (2010). Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation, 122(25): 2727–2735
Kim D H, Saetrom P, Snøve O Jr, Rossi J J (2008). MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A, 105(42): 16230–16235
Kim D H, Villeneuve L M, Morris K V, Rossi J J (2006). Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol, 13(9): 793–797
Kim J K, Samaranayake M, Pradhan S (2009). Epigenetic mechanisms in mammals. Cell Mol Life Sci, 66(4): 596–612
Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee M J, Ji H, Ehrlich L I R, Yabuuchi A, Takeuchi A, Cunniff K C, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon T J, Irizarry R A, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin S H, Weissman I L, Feinberg A P, Daley G Q (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313): 285–290
Klattenhoff C A, Scheuermann J C, Surface L E, Bradley R K, Fields P A, Steinhauser M L, Ding H, Butty V L, Torrey L, Haas S, Abo R, Tabebordbar M, Lee R T, Burge C B, Boyer L A (2013). Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell, 152(3): 570–583
Kohli R M, Zhang Y (2013). TET enzymes, TDG and the dynamics of DNA demethylation. Nature, 502(7472): 472–479
Koitabashi N, Kass D A (2012). Reverse remodeling in heart failure—mechanisms and therapeutic opportunities. Nat Rev Cardiol, 9(3): 147–157
Kolossov E, Lu Z, Drobinskaya I, Gassanov N, Duan Y, Sauer H, Manzke O, Bloch W, Bohlen H, Hescheler J, Fleischmann B K (2005). Identification and characterization of embryonic stem cellderived pacemaker and atrial cardiomyocytes. FASEB J, 19(6): 577–579
Krenning G, Zeisberg E M, Kalluri R (2010). The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol, 225(3): 631–637
Kreutziger K L, Muskheli V, Johnson P, Braun K, Wight T N, Murry C E (2011). Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A, 17(9–10): 1219–1228
Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T (2014). Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res, 114(10): 1569–1575
Laflamme M A, Chen K Y, Naumova A V, Muskheli V, Fugate J A, Dupras S K, Reinecke H, Xu C, Hassanipour M, Police S, O’Sullivan C, Collins L, Chen Y, Minami E, Gill E A, Ueno S, Yuan C, Gold J, Murry C E (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol, 25(9): 1015–1024
Laflamme M A, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, Murry C E (2005). Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol, 167(3): 663–671
Laflamme M A, Murry C E (2005). Regenerating the heart. Nat Biotechnol, 23(7): 845–856
Laflamme M A, Murry C E (2011). Heart regeneration. Nature, 473(7347): 326–335
Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong C T, Low HM, Kin Sung K W, Rigoutsos I, Loring J, Wei C L (2010). Dynamic changes in the human methylome during differentiation. Genome Res, 20(3): 320–331
Leri A, Kajstura J, Anversa P (2011). Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res, 109(8): 941–961
Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S, Gepstein L (2010). Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A, 16(1): 115–125
Li X, Wang J, Jia Z, Cui Q, Zhang C, Wang W, Chen P, Ma K, Zhou C (2013). MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One, 8(9): e74504
Lian X, Zhang J, Azarin S M, Zhu K, Hazeltine L B, Bao X, Hsiao C, Kamp T J, Palecek S P (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc, 8(1): 162–175
Lin Z, Pu WT (2014). Strategies for cardiac regeneration and repair. Sci Transl Med, 6: 239rv231
Lindsley R C, Gill J G, Kyba M, Murphy T L, Murphy K M (2006). Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development, 133(19): 3787–3796
Lu T Y, Lin B, Kim J, Sullivan M, Tobita K, Salama G, Yang L (2013). Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun, 4: 2307
Luco R F, Allo M, Schor I E, Kornblihtt A R, Misteli T (2011). Epigenetics in alternative pre-mRNA splicing. Cell, 144(1): 16–26
Luger K, Mäder A W, Richmond R K, Sargent D F, Richmond T J (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature, 389(6648): 251–260
Majumdar G, Johnson I M, Kale S, Raghow R (2008). Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide. Mol Cell Biochem, 312(1–2): 47–60
Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart A F, Smith A, Stunnenberg H G (2012). The transcriptional and epigenomic foundations of ground state pluripotency. Cell, 149(3): 590–604
Matkovich S J, Edwards J R, Grossenheider T C, de Guzman Strong C, Dorn G W 2nd (2014). Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci U S A, 111(33): 12264–12269
Nature Methods editorial (2012). Method of the Year 2011. Nat Methods, 9(1): 1
Miyamoto S, Kawamura T, Morimoto T, Ono K, Wada H, Kawase Y, Matsumori A, Nishio R, Kita T, Hasegawa K (2006). Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation, 113(5): 679–690
Movassagh M, Choy M K, Goddard M, Bennett M R, Down T A, Foo R S (2010). Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One, 5 (1): e8564
Movassagh M, Choy M K, Knowles D A, Cordeddu L, Haider S, Down T, Siggens L, Vujic A, Simeoni I, Penkett C, Goddard M, Lio P, Bennett MR, Foo R S Y (2011). Distinct epigenomic features in endstage failing human hearts. Circulation, 124(22): 2411–2422
Mujtaba S, Zeng L, Zhou M M (2007). Structure and acetyl-lysine recognition of the bromodomain. Oncogene, 26(37): 5521–5527
Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere A B, Passier R, Tertoolen L (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation, 107(21): 2733–2740
Naito A T, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A, Komuro I (2006). Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A, 103(52): 19812–19817
Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita J K (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation, 118(5): 498–506
Ng S Y, Wong C K, Tsang S Y (2010). Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol, 299(6): C1234–C1249
Nie L, Wu H J, Hsu JM, Chang S S, Labaff AM, Li C W, Wang Y, Hsu J L, Hung M C (2012). Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res, 4(2): 127–150
Nissim L, Perli S D, Fridkin A, Perez-Pinera P, Lu T K (2014). Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell, 54(4): 698–710
Nunes S S, Miklas J W, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme M A, Nanthakumar K, Gross G J, Backx P H, Keller G, Radisic M (2013). Biowire: a platform for maturation of human pluripotent stem cellderived cardiomyocytes. Nat Methods, 10(8): 781–787
Nussbaum J, Minami E, Laflamme M A, Virag J A, Ware C B, Masino A, Muskheli V, Pabon L, Reinecke H, Murry C E (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J, 21(7): 1345–1357
Osafune K, Caron L, Borowiak M, Martinez R J, Fitz-Gerald C S, Sato Y, Cowan C A, Chien K R, Melton D A (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol, 26(3): 313–315
Paige S L, Thomas S, Stoick-Cooper C L, Wang H, Maves L, Sandstrom R, Pabon L, Reinecke H, Pratt G, Keller G, Moon R T, Stamatoyannopoulos J, Murry C E (2012). A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell, 151(1): 221–232
Papait R, Condorelli G (2010). Epigenetics in heart failure. Ann N Y Acad Sci, 1188(1): 159–164
Papait R, Kunderfranco P, Stirparo G G, Latronico M V, Condorelli G (2013). Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res, 6(6): 876–883
Pascut F C, Goh H T, George V, Denning C, Notingher I (2011). Toward label-free Raman-activated cell sorting of cardiomyocytes derived from human embryonic stem cells. J Biomed Opt, 16(4): 045002
Passier R, van Laake L W, Mummery C L (2008). Stem-cell-based therapy and lessons from the heart. Nature, 453(7193): 322–329
Porrello E R, Mahmoud A I, Simpson E, Hill J A, Richardson J A, Olson E N, Sadek H A (2011). Transient regenerative potential of the neonatal mouse heart. Science, 331(6020): 1078–1080
Radisic M, Christman K L (2013). Materials science and tissue engineering: repairing the heart. Mayo Clin Proc, 88(8): 884–898
Rai M, Walthall J M, Hu J, Hatzopoulos A K (2012). Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells. Stem Cells Dev, 21(1): 54–66
Rajala K, Pekkanen-Mattila M, Aalto-Setälä K (2011). Cardiac differentiation of pluripotent stem cells. Stem Cells Int, 2011: 383709
Reinecke H, Zhang M, Bartosek T, Murry C E (1999). Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation, 100(2): 193–202
Reisman D, Glaros S, Thompson E A (2009). The SWI/SNF complex and cancer. Oncogene, 28(14): 1653–1668
Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A, Balasooriya G, Leaford D, Behrens A, Bertone P, Hendrich B (2012). NuRDmediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J, 31(3): 593–605
Rizzi R, Di Pasquale E, Portararo P, Papait R, Cattaneo P, Latronico M V, Altomare C, Sala L, Zaza A, Hirsch E, Naldini L, Condorelli G, Bearzi C (2012). Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation. Cell Death Differ, 19(7): 1162–1174
Robertson K D (2005). DNA methylation and human disease. Nat Rev Genet, 6(8): 597–610
Robey T E, Saiget M K, Reinecke H, Murry C E (2008). Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol, 45(4): 567–581
Rubart M, Pasumarthi K B, Nakajima H, Soonpaa M H, Nakajima H O, Field L J (2003). Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res, 92(11): 1217–1224
Salmanidis M, Pillman K, Goodall G, Bracken C (2014). Direct transcriptional regulation by nuclear microRNAs. Int J Biochem Cell Biol, 54: 304–311
Sanchez-Freire V, Lee A S, Hu S, Abilez O J, Liang P, Lan F, Huber B C, Ong S G, Hong W X, Huang M, Wu J C (2014). Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol, 64(5): 436–448
Santillan D A, Theisler CM, Ryan A S, Popovic R, Stuart T, Zhou MM, Alkan S, Zeleznik-Le N J (2006). Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype. Cancer Res, 66(20): 10032–10039
Santos-Rosa H, Schneider R, Bannister A J, Sherriff J, Bernstein B E, Emre N C, Schreiber S L, Mellor J, Kouzarides T (2002). Active genes are tri-methylated at K4 of histone H3. Nature, 419(6905): 407–411
Sarma K, Margueron R, Ivanov A, Pirrotta V, Reinberg D (2008). Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol, 28(8): 2718–2731
Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi M E (2007). Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells, 25(5): 1136–1144
Segers V F, Lee R T (2008). Stem-cell therapy for cardiac disease. Nature, 451(7181): 937–942
Senyo S E, Steinhauser ML, Pizzimenti C L, Yang V K, Cai L, Wang M, Wu T D, Guerquin-Kern J L, Lechene C P, Lee R T (2013). Mammalian heart renewal by pre-existing cardiomyocytes. Nature, 493(7432): 433–436
Sera T (2009). Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev, 61(7–8): 513–526
Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant N J, Gantz J, Moyes K W, Reinecke H, Van Biber B, Dardas T, Mignone J L, Izawa A, Hanna R, Viswanathan M, Gold J D, Kotlikoff M I, Sarvazyan N, Kay M W, Murry C E, Laflamme M A (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature, 489(7415): 322–325
Shiba Y, Hauch K D, Laflamme M A (2009). Cardiac applications for human pluripotent stem cells. Curr Pharm Des, 15(24): 2791–2806
Shilatifard A (2006). Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem, 75(1): 243–269
Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L (2003). Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol, 285(6): H2355–H2363
Sondermeijer B M, Bakker A, Halliani A, de Ronde M W, Marquart A A, Tijsen A J, Mulders T A, Kok M G M, Battjes S, Maiwald S, Sivapalaratnam S, Trip MD, Moerland P D, Meijers J C M, Creemers E E, Pinto-Sietsma S J (2011). Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One, 6(10): e25946
Stein A B, Jones T A, Herron T J, Patel S R, Day S M, Noujaim S F, Milstein M L, Klos M, Furspan P B, Jalife J, Dressler G R (2011). Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest, 121(7): 2641–2650
Stevens K R, Kreutziger K L, Dupras S K, Korte F S, Regnier M, Muskheli V, Nourse M B, Bendixen K, Reinecke H, Murry C E (2009). Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A, 106(39): 16568–16573
Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen S E (2011). 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol, 12(6): R54
Sucharov C, Bristow M R, Port J D (2008). miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol, 45(2): 185–192
Sullivan G J, Bai Y, Fletcher J, Wilmut I (2010). Induced pluripotent stem cells: epigenetic memories and practical implications. Mol Hum Reprod, 16(12): 880–885
Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K (2009). MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J, 73(8): 1492–1497
Tanasijevic B, Dai B, Ezashi T, Livingston K, Roberts R M, Rasmussen T P (2009). Progressive accumulation of epigenetic heterogeneity during human ES cell culture. Epigenetics, 4(5): 330–338
Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, Hashimoto H, Suzuki T, Yamashita H, Satoh Y, Egashira T, Seki T, Muraoka N, Yamakawa H, Ohgino Y, Tanaka T, Yoichi M, Yuasa S, Murata M, Suematsu M, Fukuda K (2013). Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell, 12(1): 127–137
Tompkins J D, Hall C, Chen V C, Li A X, Wu X, Hsu D, Couture L A, Riggs A D (2012). Epigenetic stability, adaptability, and reversibility in human embryonic stem cells. Proc Natl Acad Sci U S A, 109(31): 12544–12549
Trivedi C M, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger P R, Wurst W, Ferrari V A, Abrams C S, Gruber P J, Epstein J A (2007). Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med, 13(3): 324–331
Tsai M C, Manor O, Wan Y, Mosammaparast N, Wang J K, Lan F, Shi Y, Segal E, Chang H Y (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329(5992): 689–693
Tulloch N L, Muskheli V, Razumova MV, Korte F S, Regnier M, Hauch K D, Pabon L, Reinecke H, Murry C E (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res, 109(1): 47–59
Ueno S, Weidinger G, Osugi T, Kohn A D, Golob J L, Pabon L, Reinecke H, Moon R T, Murry C E (2007). Biphasic role for Wnt/ beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A, 104(23): 9685–9690
Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita J K (2011). Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One, 6(8): e23657
Van Hoof D, Dormeyer W, Braam S R, Passier R, Monshouwer-Kloots J, Ward-van Oostwaard D, Heck A J R, Krijgsveld J, Mummery C L (2010). Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res, 9(3): 1610–1618
van Rooij E, Sutherland L B, Liu N, Williams A H, McAnally J, Gerard R D, Richardson J A, Olson E N (2006). A signature pattern of stressresponsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A, 103(48): 18255–18260
Verheugt C L, Uiterwaal C S, van der Velde E T, Meijboom F J, Pieper P G, van Dijk A P, Vliegen H W, Grobbee D E, Mulder B J M (2010). Mortality in adult congenital heart disease. Eur Heart J, 31(10): 1220–1229
Voigt P, LeRoy G, Drury W J 3rd, Zee B M, Son J, Beck D B, Young N L, Garcia B A, Reinberg D (2012). Asymmetrically modified nucleosomes. Cell, 151(1): 181–193
Wamstad J A, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson K E, Ding H, Wylie J N, Pico A R, Capra J A, Erwin G, Kattman S J, Keller G M, Srivastava D, Levine S S, Pollard K S, Holloway A K, Boyer L A, Bruneau B G (2012). Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell, 151(1): 206–220
Wang G K, Zhu J Q, Zhang J T, Li Q, Li Y, He J, Qin Y W, Jing Q (2010). Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 31(6): 659–666
Xu C, Police S, Rao N, Carpenter M K (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res, 91(6): 501–508
Xu H, Yi B A, Wu H, Bock C, Gu H, Lui K O, Park J H C, Shao Y, Riley A K, Domian I J, Hu E, Willette R, Lepore J, Meissner A, Wang Z, Chien K R (2012). Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res, 22(1): 142–154
Xue T, Cho H C, Akar F G, Tsang S Y, Jones S P, Marbán E, Tomaselli G F, Li R A (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation, 111(1): 11–20
Yang L, Soonpaa M H, Adler E D, Roepke T K, Kattman S J, Kennedy M, Henckaerts E, Bonham K, Abbott G W, Linden R M, Field L J, Keller G M (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature, 453(7194): 524–528
Yang YW, Flynn R A, Chen Y, Qu K, Wan B, Wang K C, Lei M, Chang H Y (2014). Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency. Elife, 3: e02046
Yao C X, Wei Q X, Zhang Y Y, Wang WP, Xue L X, Yang F, Zhang S F, Xiong C J, Li W Y, Wei Z R, Zou Y, Zang M X (2013). miR-200b targets GATA-4 during cell growth and differentiation. RNA Biol, 10(4): 465–480
Yi F F, Yang L, Li Y H, Su P X, Cai J, Yang X C (2009). Electrophysiological development of transplanted embryonic stem cell-derived cardiomyocytes in the hearts of syngeneic mice. Arch Med Res, 40(5): 339–344
Yoon B S, Yoo S J, Lee J E, You S, Lee H T, Yoon H S (2006). Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation, 74(4): 149–159
Zaratiegui M, Irvine D V, Martienssen R A (2007). Noncoding RNAs and gene silencing. Cell, 128(4): 763–776
Zhang C L, McKinsey T A, Chang S, Antos C L, Hill J A, Olson E N (2002a). Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell, 110(4): 479–488
Zhang J, Klos M, Wilson G F, Herman A M, Lian X, Raval K K, Barron M R, Hou L, Soerens A G, Yu J, Palecek S P, Lyons G E, Thomson J A, Herron T J, Jalife J, Kamp T J (2012a). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res, 111(9): 1125–1136
Zhang L, Chen B, Zhao Y, Dubielecka P M, Wei L, Qin G J, Chin Y E, Wang Y, Zhao T C (2012b). Inhibition of histone deacetylaseinduced myocardial repair is mediated by c-kit in infarcted hearts. J Biol Chem, 287(47): 39338–39348
Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P, Cheng G, Zhao T C (2012c). Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther, 341(1): 285–293
Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N, Chang S, Ling H, Bers D M, Maier L S, Olson E N, Brown J H (2007). CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem, 282(48): 35078–35087
Zhang Y M, Hartzell C, Narlow M, Dudley S C Jr (2002). Stem cellderived cardiomyocytes demonstrate arrhythmic potential. Circulation, 106(10): 1294–1299
Zhu S, Hu X, Han S, Yu Z, Peng Y, Zhu J, Liu X, Qian L, Zhu C, Li M, Song G, Guo X (2014). Differential expression profile of long noncoding RNAs during differentiation of cardiomyocytes. Int J Med Sci, 11(5): 500–507
Zwi-Dantsis L, Gepstein L (2012). Induced pluripotent stem cells for cardiac repair. Cell Mol Life Sci, 69(19): 3285–3299
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tompkins, J.D., Riggs, A.D. An epigenetic perspective on the failing heart and pluripotent-derived-cardiomyocytes for cell replacement therapy. Front. Biol. 10, 11–27 (2015). https://doi.org/10.1007/s11515-014-1340-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11515-014-1340-0